• Companies listed on BME's growth markets increased their turnover by 17% and employment by 9% in the first half of 2025.
• In the first ten months of the year, companies on BME's growth markets raised €580 million in 91 capital increases.
At the start of 2025, marked by volatility, with tensions arising from the trade tensions / frictions and international strains affecting global markets, companies on BME's growth markets (BME Growth and BME Scaleup) achieved a combined turnover of €2.951 billion at the end of the first half of the year, representing an increase of 17.4% over the same period last year. Employment grew by 9.3% in the same period, consolidating a compound annual growth rate of 24.8% since 2019.
This positive performance demonstrates the strong resilience and ability to adapt to complex scenarios of this group of companies.
Over the last five years, companies have increased their turnover thanks to access to financing and visibility in BME's growth markets. During this period, they have recorded a compound annual growth rate (CAGR) of 23.1% in turnover and 14.9% in EBITDA, demonstrating a sustained improvement in profitability. In addition, employment has grown by 24.8% annually, exceeding 27,000 jobs in 2025, which has had a direct impact on the real economy.
The expanding companies segment, which represents the most innovative sectors within these markets, is the segment with the strongest growth. In the last year, they have increased their turnover by 17.8%; their EBITDA by 6.7% and employment by 10%. In the long term, their performance is even more remarkable, with compound annual growth of 28.5% in revenue and 30% in EBITDA since 2019. These figures confirm that SMEs entering growth markets are not only growing, but doing so solidly, expanding margins and becoming increasingly profitable.
In the first half of 2025, SOCIMIs increased their turnover by 16.6% and EBITDA by 5.1%, consolidating their position as efficient vehicles for channeling investment into real estate assets. Furthermore, their long-term performance shows a CAGR of 15.2% in revenue and 11.3% in EBITDA over the last five years.
One of the drivers of this positive performance is the use of BME's growth markets as a financing tool. At the end of October 2025, these companies had carried out 91 capital increases, raising €580 million, up from €578 million in the same period in 2024. These figures confirm the strategic role of BME Growth and BME Scaleup in channeling resources towards business projects, driving innovation and generating value in the real economy.
Since the creation of BME Growth in 2009, 877 capital increases have been carried out on BME's growth markets, raising more than €8.24 billion for companies and reaffirming their position as one of the main sources of financing for growing companies.